With a trading volume of USD 402.3 k RNXT trades 6.11 percent higher todayRenovorx (RNXT) stock rises 6.1% as investors eye its $59M market cap and potential breakthrough therapies for solid tumors and pancreatic cancer.RENOVORX INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Elliot Mercer 28/10/2026, 10:49 2 minutes to read
With a trading volume of USD 238.2 k RNXT trades 1.55 percent higher todayRenovorx (RNXT) trades at $1.31, down 15.48% from last month; 52‑week high $2.59, low $0.70, market cap $58.2M—biotech investors monitor its oncology pipeline.RENOVORX INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Jake Connors 27/10/2026, 12:58 2 minutes to read